Alnylam Pharmaceuticals
ALNY
#583
Rank
$43.41 B
Marketcap
$327.36
Share price
-1.65%
Change (1 day)
33.51%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company